BIOLOGICAL THERAPY IN PEDIATRIC RHEUMATOLOGY

dc.contributor.authorMakhpieva Guldonakhon Kobiljanovna
dc.date.accessioned2025-12-31T15:38:56Z
dc.date.issued2024-03-22
dc.description.abstractThe article presents data on unique world experience in the use of biological agents in pediatric rheumatology. Treatment with genetically engineered biological drugs improves the quality of life of children with JA and their families, ensures normal growth and development of young patients, and changes the prognosis of this previously practically incurable chronic autoimmune disease.
dc.formatapplication/pdf
dc.identifier.urihttps://scholarexpress.net/index.php/wbph/article/view/3966
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/49678
dc.language.isoeng
dc.publisherScholar Express Journals
dc.relationhttps://scholarexpress.net/index.php/wbph/article/view/3966/3372
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceWorld Bulletin of Public Health; Vol. 32 (2024): WBPH; 108-109
dc.source2749-3644
dc.subjectChildren
dc.subjectBiological Therapy
dc.subjectRheumatology
dc.titleBIOLOGICAL THERAPY IN PEDIATRIC RHEUMATOLOGY
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
kobiljanovna_2024_biological_therapy_in_pediatric_rheumato.pdf
item.page.filesection.size
145.66 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections